Towercrest Capital Management’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-5,050
| Closed | -$479K | – | 110 |
|
|
2024
Q1 | $479K | Hold |
5,050
| – | – | 0.08% | 76 |
|
|
2023
Q4 | $451K | Hold |
5,050
| – | – | 0.08% | 73 |
|
|
2023
Q3 | $369K | Buy |
+5,050
| New | +$369K | 0.07% | 79 |
|
|
2019
Q1 | – | Sell |
-8,750
| Closed | -$628K | – | 75 |
|
|
2018
Q4 | $628K | Buy |
+8,750
| New | +$628K | 0.2% | 48 |
|